Uterine Cervical Cancer Clinical Trial
Official title:
Phase I/II Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma: Analysis of Prognostic Factors and Determinants of Response: A Pilot Study
The purpose of this study is first to establish what is the ideal dose of gemcitabine, a chemotherapy agent, when given in combination with radiation. In addition, the investigators want to determine the side effects and the effectiveness of this combination. The investigators will also study several markers to try to identify markers or tests that will predict which patients will benefit more from this treatment.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01234480 -
Intended Use Study of the BD SurePath Plus™ Pap
|
||
Completed |
NCT05022511 -
Three Birds With One Stone
|
N/A | |
Recruiting |
NCT04857528 -
Detecting HPV DNA in Anal and Cervical Cancers
|
||
Completed |
NCT01755897 -
A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
|
N/A | |
Recruiting |
NCT01667211 -
Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01226264 -
Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence
|
N/A | |
Recruiting |
NCT03961191 -
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
|
||
Enrolling by invitation |
NCT01393470 -
Evaluation of Long-term HPV Vaccine Efficacy
|
N/A | |
Terminated |
NCT00421096 -
Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer
|
Phase 2 | |
Terminated |
NCT01284348 -
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer
|
Phase 2 | |
Recruiting |
NCT03961178 -
A Cohort Study for the Following up of Conization
|
||
Terminated |
NCT02317302 -
FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
|
Phase 1 | |
Not yet recruiting |
NCT06254846 -
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).
|
N/A | |
Not yet recruiting |
NCT05824494 -
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
|
Phase 2 | |
Recruiting |
NCT03960879 -
DNA Methylation for Screening Uterine Cervical Lesions
|
||
Recruiting |
NCT04886700 -
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
|
Phase 2 | |
Completed |
NCT02095119 -
A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT05231993 -
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening
|
N/A | |
Recruiting |
NCT02036164 -
Adjuvant Chemotherapy for Locally Advanced Cervical Cancer
|
Phase 3 | |
Recruiting |
NCT04974424 -
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
|